DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Viread (Tenofovir Disoproxil) - Maternal Exposure During Pregnancy - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Maternal Exposure During Pregnancy (13)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Viread (Tenofovir Disoproxil) where reactions include maternal exposure during pregnancy. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Viread side effects in 36 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27

Patient: 36 year old female

Reactions: Maternal Exposure During Pregnancy, Abortion Induced

Drug(s) suspected as cause:
Epivir
    Dosage: 100mgd per day
    Administration route: Oral
    Indication: Antiviral Treatment

Norvir
    Dosage: 100mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy

Reyataz
    Dosage: 300mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy

Viread
    Dosage: 300mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy



Possible Viread side effects in

Reported by a consumer/non-health professional from United States on 2012-08-10

Patient:

Reactions: Maternal Exposure During Pregnancy, Abortion Spontaneous

Drug(s) suspected as cause:
Combivir
    Dosage: 2 df, unk
    Administration route: Oral
    Start date: 2012-05-28

Isentress
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-03-28
    End date: 2012-05-23

Kaletra
    Dosage: 4 df, unk
    Administration route: Oral
    Start date: 2012-05-28

Viread
    Dosage: 300 mg, qd
    Administration route: Oral
    Start date: 2012-03-28
    End date: 2012-05-23



Possible Viread side effects in 37 year old female

Reported by a health professional (non-physician/pharmacist) from Argentina on 2012-08-08

Patient: 37 year old female

Reactions: Endometrial Disorder, Maternal Exposure During Pregnancy, Abortion Spontaneous

Drug(s) suspected as cause:
Epivir
    Dosage: 300mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-09-21

Kaletra
    Dosage: 4tab unknown
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-09-21

Viread
    Dosage: 300mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-09-21



Possible Viread side effects in 35 year old female

Reported by a physician from Mexico on 2012-08-06

Patient: 35 year old female

Reactions: Maternal Exposure During Pregnancy, Abortion Spontaneous

Drug(s) suspected as cause:
Combivir
    Dosage: 2tab per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2012-05-28

Kaletra
    Dosage: 4tab per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2012-05-28

Raltegravir
    Dosage: 400mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2012-03-28
    End date: 2012-05-23

Viread
    Dosage: 300mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2012-03-28
    End date: 2012-05-23



Possible Viread side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-02

Patient:

Reactions: Maternal Exposure During Pregnancy, Abortion Spontaneous

Drug(s) suspected as cause:
Combivir
    Dosage: unk df, unk
    Administration route: Oral
    Start date: 2012-05-28

Isentress
    Dosage: unk mg, unk
    Administration route: Oral
    Start date: 2012-03-28
    End date: 2012-05-23

Kaletra
    Dosage: unk df, unk
    Administration route: Oral
    Start date: 2012-05-28

Viread
    Dosage: unk mg, unk
    Administration route: Oral
    Start date: 2012-03-28
    End date: 2012-05-23



Possible Viread side effects in 37 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-23

Patient: 37 year old female

Reactions: Endometrial Disorder, Maternal Exposure During Pregnancy, Abortion Spontaneous

Drug(s) suspected as cause:
Epivir
    Dosage: 300mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-09-21

Kaletra
    Dosage: 4tab unknown
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-09-21

Viread
    Dosage: 300mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-09-21



Possible Viread side effects in 35 year old female

Reported by a health professional (non-physician/pharmacist) from Mexico on 2012-07-23

Patient: 35 year old female

Reactions: Maternal Exposure During Pregnancy, Abortion Spontaneous

Drug(s) suspected as cause:
Combivir
    Dosage: 2tab per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2012-05-28

Kaletra
    Dosage: 4tab per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2012-05-28

Reyataz
    Dosage: 400mg per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2012-03-28
    End date: 2012-05-23

Viread
    Dosage: 300mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2012-03-28
    End date: 2012-05-23



Possible Viread side effects in 44 year old female

Reported by a physician from Thailand on 2012-07-16

Patient: 44 year old female

Reactions: Maternal Exposure During Pregnancy, Abortion Spontaneous

Drug(s) suspected as cause:
Epivir
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2012-03-14

Kaletra
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2012-03-14

Norvir
    Dosage: 150mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2010-11-03
    End date: 2012-03-12

Reyataz
    Dosage: 300mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2010-11-03
    End date: 2012-03-12

Truvada
    Dosage: 1tab per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2010-11-03
    End date: 2012-03-12

Viread
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2012-03-14



Possible Viread side effects in 44 year old female

Reported by a health professional (non-physician/pharmacist) from Thailand on 2012-07-03

Patient: 44 year old female

Reactions: Maternal Exposure During Pregnancy, Abortion Spontaneous

Drug(s) suspected as cause:
Epivir
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2012-03-14

Kaletra
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2012-03-14

Norvir
    Dosage: 150mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2010-11-03
    End date: 2012-03-12

Reyataz
    Dosage: 1tab per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2010-11-03
    End date: 2012-03-12

Truvada
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2010-11-03
    End date: 2012-03-12

Viread
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2012-03-14



Possible Viread side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-10

Patient: female

Reactions: Intra-Uterine Death, Maternal Exposure During Pregnancy, Inflammation

Adverse event resulted in: death

Drug(s) suspected as cause:
Epivir
    Indication: Maternal Exposure During Pregnancy

Kaletra
    Indication: Maternal Exposure During Pregnancy

Viread
    Indication: Maternal Exposure During Pregnancy



Possible Viread side effects in 39 year old female

Reported by a physician from United States on 2011-10-10

Patient: 39 year old female

Reactions: Thrombosis, Premature Separation of Placenta, Maternal Exposure During Pregnancy, Stillbirth, Inflammation

Drug(s) suspected as cause:
Epivir
    Dosage: 300 mg daily, taken at conception
    Administration route: Oral
    Indication: Antiviral Treatment
    Start date: 2010-07-15

Kaletra
    Dosage: 4 tablets daily, taken at conception
    Administration route: Oral
    Indication: Antiviral Treatment
    Start date: 2010-07-15

Viread
    Dosage: 300 mg daily, taken at conception
    Administration route: Oral
    Indication: Antiviral Treatment
    Start date: 2010-07-15



Possible Viread side effects in male

Reported by a health professional (non-physician/pharmacist) from Argentina on 2011-10-07

Patient: male, weighing 1.6 kg (3.5 pounds)

Reactions: Premature Baby, Maternal Exposure During Pregnancy, Ventricular Septal Defect

Drug(s) suspected as cause:
Kaletra
    Dosage: 4tab per day
    Indication: HIV Infection
    Start date: 2010-02-15

Lamivudine + Zidovudine
    Dosage: 2tab per day
    Indication: HIV Infection
    Start date: 2009-10-15

Nevirapine
    Dosage: 400mgd per day
    Indication: HIV Infection
    Start date: 2009-10-15
    End date: 2010-02-15

Viread
    Dosage: 300mgd per day
    Indication: HIV Infection
    Start date: 2010-02-15



Possible Viread side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-05

Patient: female

Reactions: Intra-Uterine Death, Maternal Exposure During Pregnancy, Inflammation

Adverse event resulted in: death

Drug(s) suspected as cause:
Epivir
    Indication: Maternal Exposure During Pregnancy

Kaletra
    Indication: Maternal Exposure During Pregnancy

Viread
    Indication: Maternal Exposure During Pregnancy

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017